Table 3: Distribution of susceptibility profiles of isolated Vibrio cholerae O1 strains to ten antibiotics tested (n = 4382).
|
Antibiotics |
Profil |
||||
|
ND n (%) |
I n (%) |
S n (%) |
R n (%) |
Total N (%) |
|
|
TE |
539 (12.3) |
92 (2.1) |
3117 (71.1) |
634 (14.5) |
4382 (100) |
|
AM |
556 (12.7) |
254 (5.8) |
297 (6.8) |
3275 (74.7) |
4382 (100) |
|
CI |
198 (4.5) |
239 (5.5) |
3612 (82.4) |
333 (7.6) |
4382 (100) |
|
SXT |
393 (9.0) |
34 (0.8) |
361 (8.2) |
3594 (82.0) |
4382 (100) |
|
C |
435 (9.9) |
120 (2.7) |
813 (18.6) |
3014 (68.8) |
4382 (100) |
|
NA |
358 (8.2) |
118 (2.7) |
236 (5.4) |
3670 (83.8) |
4382 (100) |
|
E |
450 (10.3) |
384 (8.8) |
323 (7.4) |
3225 (73.6) |
4382 (100) |
|
DO |
718 (16.4) |
146 (3.3) |
2202 (50.3) |
1316 (30.0) |
4382 (100) |
|
NOR |
273 (6.2) |
115 (2.6) |
3825 (87.3) |
169 (3.9) |
4382 (100) |
|
AZ |
2336 (53.3) |
31 (0.7) |
1949 (44.5) |
66 (1.5) |
4382 (100) |
TE: Tetracycline; AM: Ampicillin; CI: Ciprofloxacin; SXT: Sulfamethoxazole/Trimethoprim; C: Chloramphenicol; NA: Nalidixic Acid; E: Erythromycin; DO: Doxycycline; NOR: Norfloxacin; AZ: Azithromycin; I: Intermediate; ND: Not Determined; R: Resistant: S: Susceptible